IMU - Imugene Limited (ASX) Stock Forum

ASX:IMU - Imugene Limited is an Australian biotechnology company that focuses on developing immunotherapies for the treatment of cancer. It is listed on the Australian Securities Exchange (ASX) and is a popular stock among Aussie stock traders. Join our forum to discuss ASX:IMU and other promising stocks in the biotech industry.
annb0t
IMU Ann: Notification regarding unquoted securities - IMU - 10th Mar 2023, 5:08pm
Replies
0
Views
105
annb0t
annb0t
annb0t
IMU Ann: Application for quotation of securities - IMU - 10th Mar 2023, 5:04pm
Replies
0
Views
121
annb0t
annb0t
annb0t
IMU Ann: Change of Registered Office - 8th Mar 2023, 9:49am
Replies
0
Views
176
annb0t
annb0t
annb0t
IMU News: Imugene thrilled as first patients dosed in VAXINIA MAST combination study - 4th Mar 2023, 3:40am
Replies
0
Views
159
annb0t
annb0t
annb0t
IMU Ann: First Patients Dosed in Combination Study of VAXINIA - 3rd Mar 2023, 9:41am
Replies
0
Views
102
annb0t
annb0t
annb0t
IMU Ann: Imugene appoints CFO Mike Tonroe as Company Secretary - 2nd Mar 2023, 2:05pm
Replies
0
Views
119
annb0t
annb0t
GazDix
IMU Discussion
3 4 5
Replies
87
Views
9K
Slymeat
Slymeat
annb0t
IMU Ann: Half Yearly Report and Accounts - 28th Feb 2023, 12:07pm
Replies
0
Views
100
annb0t
annb0t
annb0t
IMU Ann: Application for quotation of securities - IMU - 22nd Feb 2023, 5:30pm
Replies
0
Views
123
annb0t
annb0t
annb0t
IMU Ann: Imugene PD1-Vaxx Immunotherapy Patent Granted in the US - 10th Feb 2023, 8:41am
Replies
0
Views
167
annb0t
annb0t
annb0t
IMU Ann: Imugene VAXINIA trial advances to Combination Cohort - 2nd Feb 2023, 9:50am
Replies
0
Views
143
annb0t
annb0t
annb0t
IMU News: Celularity Completes Strategic Review of 2023 Initiatives, Including Anticipated Biomaterials Produc - 27th Jan 2023, 8:17am
Replies
0
Views
150
annb0t
annb0t
annb0t
IMU Ann: Quarterly Activities/Appendix 4C Cash Flow Report - 27th Jan 2023, 9:51am
Replies
0
Views
115
annb0t
annb0t
annb0t
IMU News: Imugene off to strong start to 2023 with JP Morgan Healthcare Conference - 24th Jan 2023, 3:45am
Replies
0
Views
135
annb0t
annb0t
annb0t
IMU Ann: HER-Vaxx and CF33 Platforms Featured at ASCO Symposium - 20th Jan 2023, 9:07am
Replies
0
Views
119
annb0t
annb0t
annb0t
IMU Ann: Imugene Presentation to the JP Morgan Healthcare Conference - 9th Jan 2023, 9:41am
Replies
0
Views
220
annb0t
annb0t
annb0t
IMU Ann: Imugene Receives Vaxinia Ethics Approval in Australia - 9th Jan 2023, 9:31am
Replies
0
Views
135
annb0t
annb0t
annb0t
IMU Ann: Letter to Shareholders - 6th Jan 2023, 10:28am
Replies
0
Views
265
annb0t
annb0t
annb0t
IMU Ann: Notification regarding unquoted securities - IMU - 22nd Dec 2022, 3:36pm
Replies
0
Views
166
annb0t
annb0t
annb0t
IMU Ann: Notification regarding unquoted securities - IMU - 22nd Dec 2022, 3:32pm
Replies
0
Views
134
annb0t
annb0t
You must log in or register to post here.

Share this page

Top Bottom